Acute Rejection of Liver Transplant
2
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Sirolimus
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 2 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
SRL (Sirolimus) Withdrawal
Human Microbiota and Liver Transplant
Research Network
Common Treatments
- Sirolimus1
Active Sponsors
- Northwestern University1
- Hospital Vall d'Hebron1
Top Investigators
Department of HBP Surgery and Transplants, Hospital Vall d´Hebron (Barcelona, Spain)
Department of Gastroenterology Disease, Hospital Vall d´Hebron (Barcelona, Spain)
Department of Gastroenterology Disease, Hospital Vall d´Hebron (Barcelona, Spain)
Physiology and Pathophysiology of the Digestive Tract, Institut de Recerca Vall d´Hebron, Barcelona (Spain)
Northwestern University
Related Conditions
- Intestinal Microbiota1
- Infection1
- Effects Of Immunosuppressant Therapy1
- Complication Of Transplanted Liver1